Abstract 16263: Liver Fibrosis Staging by FIB-4 Index Predicts Incident Heart Failure, MACE, and Mortality in MASLD: Implications for the AHA Cardiovascular-Kidney-Metabolic Framework
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of adults globally, and cardiovascular disease is the leading cause of death in this population. The Fibrosis-4 (FIB-4) index has been validated as an independent predictor of MACE and HF hospitalization beyond tra...